Robin Ali

Robin Ali is Professor of Human Molecular Genetics at King’s College London and Head of the KCL Centre for Gene Therapy and Regenerative Medicine and Director of the KCL Gene Therapy Vector Facility. The main focus of Robin Ali’s research is the development of gene and cell therapy for the treatment of retinal disorders from pre-clinical proof-of-concept studies through to clinical trials. He is a recent past President of ESGCT and is an Associate Editor of Human Gene Therapy.